Literature DB >> 34033079

Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.

Lyandysha V Zholudeva1, Ying Jin1, Liang Qiang1, Michael A Lane1, Itzhak Fischer2.   

Abstract

Neural stem cells (NSCs) are a valuable tool for the study of neural development and function as well as an important source of cell transplantation strategies for neural disease. NSCs can be used to study how neurons acquire distinct phenotypes and how the interactions between neurons and glial cells in the developing nervous system shape the structure and function of the CNS. NSCs can also be used for cell replacement therapies following CNS injury targeting astrocytes, oligodendrocytes, and neurons. With the availability of patient-derived induced pluripotent stem cells (iPSCs), neurons prepared from NSCs can be used to elucidate the molecular basis of neurological disorders leading to potential treatments. Although NSCs can be derived from different species and many sources, including embryonic stem cells (ESCs), iPSCs, adult CNS, and direct reprogramming of nonneural cells, isolating primary NSCs directly from fetal tissue is still the most common technique for preparation and study of neurons. Regardless of the source of tissue, similar techniques are used to maintain NSCs in culture and to differentiate NSCs toward mature neural lineages. This chapter will describe specific methods for isolating and characterizing multipotent NSCs and neural precursor cells (NPCs) from embryonic rat CNS tissue (mostly spinal cord) and from human ESCs and iPSCs as well as NPCs prepared by reprogramming. NPCs can be separated into neuronal and glial restricted progenitors (NRP and GRP, respectively) and used to reliably produce neurons or glial cells both in vitro and following transplantation into the adult CNS. This chapter will describe in detail the methods required for the isolation, propagation, storage, and differentiation of NSCs and NPCs isolated from rat and mouse spinal cords for subsequent in vitro or in vivo studies as well as new methods associated with ESCs, iPSCs, and reprogramming.

Entities:  

Keywords:  Cell transplantation; Embryonic stem cells; Induces pluripotent cells; Neural progenitor cells; Neurons; Spinal cord injury

Mesh:

Year:  2021        PMID: 34033079     DOI: 10.1007/978-1-0716-1437-2_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  43 in total

1.  Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS.

Authors:  Angelo C Lepore; Steven S W Han; Carla J Tyler-Polsz; Jingli Cai; Mahendra S Rao; Itzhak Fischer
Journal:  Neuron Glia Biol       Date:  2004-05

2.  Direct reprogramming of mouse fibroblasts to neural progenitors.

Authors:  Janghwan Kim; Jem A Efe; Saiyong Zhu; Maria Talantova; Xu Yuan; Shufen Wang; Stuart A Lipton; Kang Zhang; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-26       Impact factor: 11.205

Review 3.  Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.

Authors:  Michael A Lane; Angelo C Lepore; Itzhak Fischer
Journal:  Expert Rev Neurother       Date:  2016-12-21       Impact factor: 4.618

Review 4.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

Review 5.  Neural tissue transplantation and CNS trauma: anatomical and functional repair of the injured spinal cord.

Authors:  P J Reier; D K Anderson; F J Thompson; B T Stokes
Journal:  J Neurotrauma       Date:  1992-03       Impact factor: 5.269

6.  Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.

Authors:  Dhruv Sareen; Geneviève Gowing; Anais Sahabian; Kevin Staggenborg; Renée Paradis; Pablo Avalos; Jessica Latter; Loren Ornelas; Leslie Garcia; Clive N Svendsen
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

Review 7.  Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.

Authors:  Ghanshyam Upadhyay; Sharmila Shankar; Rakesh K Srivastava
Journal:  Mol Neurobiol       Date:  2014-09-23       Impact factor: 5.590

8.  Drug screening for ALS using patient-specific induced pluripotent stem cells.

Authors:  Naohiro Egawa; Shiho Kitaoka; Kayoko Tsukita; Motoko Naitoh; Kazutoshi Takahashi; Takuya Yamamoto; Fumihiko Adachi; Takayuki Kondo; Keisuke Okita; Isao Asaka; Takashi Aoi; Akira Watanabe; Yasuhiro Yamada; Asuka Morizane; Jun Takahashi; Takashi Ayaki; Hidefumi Ito; Katsuhiro Yoshikawa; Satoko Yamawaki; Shigehiko Suzuki; Dai Watanabe; Hiroyuki Hioki; Takeshi Kaneko; Kouki Makioka; Koichi Okamoto; Hiroshi Takuma; Akira Tamaoka; Kazuko Hasegawa; Takashi Nonaka; Masato Hasegawa; Akihiro Kawata; Minoru Yoshida; Tatsutoshi Nakahata; Ryosuke Takahashi; Maria C N Marchetto; Fred H Gage; Shinya Yamanaka; Haruhisa Inoue
Journal:  Sci Transl Med       Date:  2012-08-01       Impact factor: 17.956

9.  Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury.

Authors:  Paul Lu; Grace Woodruff; Yaozhi Wang; Lori Graham; Matt Hunt; Di Wu; Eileen Boehle; Ruhel Ahmad; Gunnar Poplawski; John Brock; Lawrence S B Goldstein; Mark H Tuszynski
Journal:  Neuron       Date:  2014-08-07       Impact factor: 17.173

Review 10.  Emergent properties of neural repair: elemental biology to therapeutic concepts.

Authors:  S Thomas Carmichael
Journal:  Ann Neurol       Date:  2016-04-21       Impact factor: 10.422

View more
  3 in total

Review 1.  Electroactive Scaffolds to Improve Neural Stem Cell Therapy for Spinal Cord Injury.

Authors:  Anthea R Mutepfa; John G Hardy; Christopher F Adams
Journal:  Front Med Technol       Date:  2022-02-22

2.  Optimal therapeutic conditions for the neural stem cell-based management of ischemic stroke: a systematic review and network meta-analysis based on animal studies.

Authors:  Yongna Yang; Xurui Hu; Qijie Qin; Fanling Kong; Xiaolan Peng; Jing Zhao; Jianghua Si; Zhilong Yang; Shoupin Xie
Journal:  BMC Neurol       Date:  2022-09-13       Impact factor: 2.903

Review 3.  Elucidating the Pivotal Neuroimmunomodulation of Stem Cells in Spinal Cord Injury Repair.

Authors:  Seidu A Richard; Marian Sackey
Journal:  Stem Cells Int       Date:  2021-07-23       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.